SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell MedX Corp. – ‘10-Q’ for 2/28/21 – ‘ZIP’

On:  Friday, 4/9/21, at 1:53pm ET   ·   For:  2/28/21   ·   Accession #:  1393905-21-193   ·   File #:  0-54500

Previous ‘10-Q’:  ‘10-Q’ on 1/14/21 for 11/30/20   ·   Next:  ‘10-Q’ on 10/14/21 for 8/31/21   ·   Latest:  ‘10-Q’ on 4/15/24 for 2/29/24   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Cell Medx Corp. - Form 10-Q SEC Filing              HTML    522K 
 2: EX-10.32    Loan December 14, 2020                              HTML     20K 
 3: EX-10.33    Loan December 23, 2020                              HTML     20K 
 4: EX-10.34    Loan January 21, 2021                               HTML     20K 
 5: EX-10.35    Loan February 16, 2021                              HTML     20K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     16K 
16: R1          Document and Entity Information                     HTML     64K 
17: R2          Condensed Consolidated Balance Sheets               HTML    100K 
18: R3          Condensed Consolidated Balance Sheets -             HTML     23K 
                Parenthetical                                                    
19: R4          Condensed Consolidated Statements of Operations     HTML     86K 
20: R5          Condensed Consolidated Statement of Stockholders'   HTML     85K 
                Deficit                                                          
21: R6          Condensed Consolidated Statements of Cash Flows     HTML     92K 
22: R7          Organization and Nature of Operations               HTML     23K 
23: R8          Related Party Transactions Disclosure               HTML     35K 
24: R9          Inventory Disclosure                                HTML     19K 
25: R10         Other Current Assets Disclosure                     HTML     18K 
26: R11         Equipment Disclosure                                HTML     24K 
27: R12         Revenue Disclosure                                  HTML     29K 
28: R13         Notes and Advances Payable Disclosure               HTML     48K 
29: R14         Share Capital Disclosure                            HTML     49K 
30: R15         Related Party Transactions Disclosure: Schedule of  HTML     26K 
                Amounts Due to Related Parties (Tables)                          
31: R16         Related Party Transactions Disclosure: Schedule of  HTML     25K 
                Transactions with Related Parties (Tables)                       
32: R17         Equipment Disclosure: Change in book value of the   HTML     24K 
                equipment (Tables)                                               
33: R18         Revenue Disclosure: Schedule of Revenue and         HTML     29K 
                Associated Costs (Tables)                                        
34: R19         Notes and Advances Payable Disclosure: Schedule of  HTML     38K 
                Short-term Loans and Advances Outstanding (Tables)               
35: R20         Share Capital Disclosure: Schedule of Stock Option  HTML     26K 
                Activity (Tables)                                                
36: R21         Share Capital Disclosure: Schedule of Stock         HTML     22K 
                Options Outstanding (Tables)                                     
37: R22         Share Capital Disclosure: Schedule of Warrant       HTML     26K 
                Activity (Tables)                                                
38: R23         Share Capital Disclosure: Schedule of Warrant       HTML     24K 
                Details (Tables)                                                 
39: R24         Organization and Nature of Operations (Details)     HTML     20K 
40: R25         Related Party Transactions Disclosure: Schedule of  HTML     33K 
                Amounts Due to Related Parties (Details)                         
41: R26         Related Party Transactions Disclosure: Schedule of  HTML     29K 
                Transactions with Related Parties (Details)                      
42: R27         Inventory Disclosure (Details)                      HTML     21K 
43: R28         Other Current Assets Disclosure (Details)           HTML     21K 
44: R29         Equipment Disclosure: Change in book value of the   HTML     27K 
                equipment (Details)                                              
45: R30         Revenue Disclosure: Schedule of Revenue and         HTML     43K 
                Associated Costs (Details)                                       
46: R31         Notes and Advances Payable Disclosure: Schedule of  HTML     44K 
                Short-term Loans and Advances Outstanding                        
                (Details)                                                        
47: R32         Notes and Advances Payable Disclosure (Details)     HTML     58K 
48: R33         Share Capital Disclosure (Details)                  HTML     42K 
49: R34         Share Capital Disclosure: Schedule of Stock Option  HTML     31K 
                Activity (Details)                                               
50: R35         Share Capital Disclosure: Schedule of Stock         HTML     27K 
                Options Outstanding (Details)                                    
51: R36         Share Capital Disclosure: Schedule of Warrant       HTML     25K 
                Activity (Details)                                               
52: R37         Share Capital Disclosure: Schedule of Warrant       HTML     31K 
                Details (Details)                                                
54: XML         IDEA XML File -- Filing Summary                      XML     91K 
15: XML         XBRL Instance -- cmxc-20210228_htm                   XML    765K 
53: EXCEL       IDEA Workbook of Financial Reports                  XLSX     46K 
10: EX-101.CAL  XBRL Calculations -- cmxc-20210228_cal               XML     62K 
11: EX-101.DEF  XBRL Definitions -- cmxc-20210228_def                XML    254K 
12: EX-101.LAB  XBRL Labels -- cmxc-20210228_lab                     XML    451K 
13: EX-101.PRE  XBRL Presentations -- cmxc-20210228_pre              XML    384K 
14: EX-101.SCH  XBRL Schema -- cmxc-20210228                         XSD    143K 
55: JSON        XBRL Instance as JSON Data -- MetaLinks              175±   247K 
56: ZIP         XBRL Zipped Folder -- 0001393905-21-000193-xbrl      Zip     89K 


‘ZIP’   —   XBRL Zipped Folder — 0001393905-21-000193-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:cmxc-20210228.htm
cmxc-20210228.xsd
cmxc-20210228_cal.xml
cmxc-20210228_def.xml
cmxc-20210228_lab.xml
cmxc-20210228_pre.xml
cmxc_ex1032.htm
cmxc_ex1033.htm
cmxc_ex1034.htm
cmxc_ex1035.htm
cmxc_ex311.htm
cmxc_ex312.htm
cmxc_ex321.htm
cmxc_ex322.htm


15 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Cell MedX Corp.                   10-Q        2/29/24   53:2.7M                                   Empire Stock Transf… Inc
 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc
 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc
 4/19/23  Cell MedX Corp.                   10-Q        8/31/22   51:2.2M                                   Empire Stock Transf… Inc
 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
 4/11/22  Cell MedX Corp.                   10-Q        2/28/22   56:2.5M                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   424B3                  1:365K                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   10-Q        8/31/21   50:2.2M                                   Empire Stock Transf… Inc
10/12/21  Cell MedX Corp.                   424B3                  1:705K                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   424B3                  1:501K                                   Empire Stock Transf… Inc


15 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
 4/14/20  Cell MedX Corp.                   10-Q        2/29/20   67:2.2M                                   Empire Stock Transf… Inc
 1/31/20  Cell MedX Corp.                   8-K:1,9     1/29/20    3:69K                                    Empire Stock Transf… Inc
 1/14/20  Cell MedX Corp.                   10-Q       11/30/19   65:2.2M                                   Empire Stock Transf… Inc
12/31/18  Cell MedX Corp.                   8-K:1,3,9  12/27/18    3:248K                                   Empire Stock Transf… Inc
 9/13/18  Cell MedX Corp.                   10-K        5/31/18   85:3M                                     Empire Stock Transf… Inc
10/17/17  Cell MedX Corp.                   10-Q        8/31/17   59:2.2M                                   Empire Stock Transf… Inc
 8/11/15  Cell MedX Corp.                   8-K:5,9     8/11/15    3:172K                                   Ideal Connection, Inc/FA
11/18/14  Cell MedX Corp.                   8-K:1,9    11/13/14    2:48K                                    Ideal Connection, Inc/FA
11/03/14  Cell MedX Corp.                   8-K:1,9    10/28/14    2:60K                                    Ideal Connection, Inc/FA
10/17/14  Cell MedX Corp.                   8-K:1,9    10/16/14    3:407K                                   Ideal Connection, Inc/FA
10/09/14  Cell MedX Corp.                   10-Q        8/31/14   37:2.9M                                   Ideal Connection, Inc/FA
10/13/10  Cell MedX Corp.                   S-1/A                  8:1.2M                                   Toppan Merrill/FA
 7/13/10  Cell MedX Corp.                   S-1                   11:921K                                   Toppan Merrill/FA
Top
Filing Submission 0001393905-21-000193   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 9:01:02.2am ET